// App-Quantinova.ai

931 : Outcome of Younger Adults with Philadelphia Chromosome (Ph)-Negative Acute Lymphoblastic Leukemia (ALL) in First Relapse: A Graall Study

Researchers

Presenter

  • Alexandre Desjonqueres

Principal Investigators

  • Resident

  • Patrice Chevallier

  • Mathilde Hunault

  • Pascal Turlure

  • Marc Renaud

  • Xavier Thomas

  • Francoise Huguet

  • Thibault Leguay

  • Marc Bernard

  • Jacques-Olivier Bay

  • Emmanuelle Tavernier

  • Aude Charbonnier

  • Francoise Isnard

Medical Centers

  • Centre Hospitalier Lyon-Sud, Pierre-Benite, France

  • Hematology, CHU, Angers, France

  • Cytogenetics, CHU Timone, Marseille, France

  • Hematology, Hopital Purpan, Universite Toulouse, Toulouse, France

  • CHU Dupuytren, Universite Limoges, Limoges, France

  • Hopital Bretonneau, Tours, France

  • CHU Rennes, Rennes, France

  • CHU Robert Debre, Reims, France

  • CHU St Louis, Paris, France

  • CHU Estaing, Hematologie clinique adulte et Therapie cellulaire, Clermont-Ferrand, France

  • Hematology, Hospital Saint Antoine, Paris, France,

  • Department of Hematology, CHU, Bordeaux,, Bordeaux, France

  • Coordination, Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL), Lyon, France

  • Pediatric Hematology, Nantes University Hospital, Nantes, France

Locations

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • T-cell acute lymphoblastic leukemia

Biomarkers

  • Solute Carrier Family 12 Member 2

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved